The Testing Stream aims to procure, test and evaluate innovative late stage pre-commercial prototypes. Eligible applicants can receive up to $550,000 to test their prototypes in real life settings.
Call for prototypes sponsor:
National Research Council of Canada
February 3, 2022
February 24, 2022, 14:00 Eastern Standard Time
The National Research Council of Canada needs to push the photon detection at the quantum level for biological research applications. We invite you to develop a state-of-the-art, preclinical optical imager that spans a broad optical range from 400nm to 1700nm, with high (quantum level) photon detection sensitivity (1-1000 photons/cm2/sec), and an appropriate setup for tissue to live animal imaging.
The proposed innovation must:
- Be a practical application of quantum sensing in providing a solution to the Problem Statement.
- Represent a significant sensitivity improvement to be able to visualize ultra-low single photon emission from living systems, including bio-photons within integration time of 60s or less. Read noise and dark noise must be kept to an absolute minimum.
- Be flexible for both ex-vivo tissue and small rodent animal (mouse and rat) studies.
The proposed innovation must not:
- Be intended for clinical imaging applications in humans
The proposed innovation must be able to demonstrate the following minimum criteria for an optical imaging system:
- Ability to have sufficient quantum sensitivity to detect photon emission in the range of 1-1000 photons/cm2/sec and/or as low as the thermal radiation level detected from tissues.
- Ability to detect photons in the desired optical detection range of 400-1700nm.
- Ability to conduct fluorescence excitation studies via a multiple laser capable of exciting the sample from 400-1040nm.
- Ability to image more than one animal (e.g. 2-3 animals) without opening the system.
- Incorporate systems with video rate detection capabilities.
- Ability to automatically adjust and collect emission at different wavelengths (e.g. filter wheel with a minimum 8 slots or a spectral band detector).
- Ability to automatically adjust sample stage in the X, Y and Z direction for sample focus.
- Imaging system must be contained and operated in a completely dark chamber for live sample imaging.
- Incorporate gaseous anesthesia and gas scavenging for live animal imaging (i.e. mice and/or rats).
- Ability for temperature control of animal.
- Incorporation of catheter tubing inlets for drug injections.
- Incorporate automated software control of sample light exposure and/or detection, in a dynamic manner, to obtain maximum signal while avoiding system saturation at different timepoints.
- Incorporate software for heat map image display and analysis, including intensity normalization between various exposures and detection settings at different time points, and the ability to derive photon intensity information from captured images using various region of interest selection tools.
In order to be considered having met the additional outcomes and to what degree, the proposed innovation should demonstrate:
- Having complete software control of hardware (i.e. stage, lens, wavelengths, filters)
- Being flexible for interchanging between ex-vivo tissues to live animals.
- Having user friendly software for easy operation by biologists.
Biophotons are ultra-weak light (ranging from 1-1000 photons/ cm2/sec) that are emitted spontaneously by biological systems, such as tissues and animals. They are considered non-thermal in origin. Although there wavelength emission spectrum and the mechanism for this emission have not been clearly identified, most of the work has been done in the visible range (due to lack of ultrasensitive detectors in the shortwave infrared window), however, there is evidence that biophotons originate from radiative decay of electronically excited molecular species in both the visible and the shortwave infrared spectrum. Although the role and function of biophotons are still under investigation, they are believed to participate in cellular communication and indicate the state of biological tissues.
The main challenge of studying biophotons is their ultra-weak intensity, which requires ultrasensitive detectors with very low noise levels. To resolve biophoton detection in biological samples, we need single-photon imaging system, spanning the visible to shortwave infrared spectrum, coupled with spectral filters to achieve spatial and spectral resolution. These components must be built in a single, flexible platform that combines sufficient sensitivity, resolution and optical tools required to perform bio-photon measurements in a diverse set of biological samples.
Bidders are required to certify program eligibility as part of their proposal. Selected Bidders will be required to re-certify eligibility at any phase under the ISC program. To remain eligible for the Testing Stream, eligibility criteria must be met at all times.
The Bidder must meet the definition of a Canadian Bidder.
80% of the financial proposal costs, must be Canadian goods or Canadian services, as defined in the Canadian Content certification.
The Bidder must be the owner of the Intellectual Property (IP) for the proposed innovation, or have a licence to the IP rights from a Canadian licensor for the proposed innovation and not be infringing on any IP rights.
The proposed innovation must not be openly available in the marketplace, and must not have been previously sold on a commercial basis as of the date of this bid submission. (Please note: Once your company submits a proposal for an innovation to the program, the innovation is able to be sold commercially)
Previously pre-qualified innovation:
The proposed innovation or any other versions of the proposed innovation must not have been previously awarded a contract in any of the Innovative Solutions Canada Streams, the Build in Canada Innovation Program (BCIP) or its predecessor, the Canadian Innovation Commercialization Program (CICP), and it is not currently active in a pool of pre-qualified Innovations.
A proposed innovation that is currently active in a pool will be accepted only once the bid validity period for that proposal has expired or the Bidder has withdrawn their innovation from the relevant pool in collaboration with the Contracting Authority. The Bidder agrees that having pre-qualified into a pool does not guarantee pre-qualifying under the current solicitation.
The Bidder's financial proposal must not exceed the relevant component's maximum funding amounts which are $550,000.00 CAD for the standard component (applicable taxes, shipping, and travel and living expenses are extra, as applicable).
Eligibility specific to the small and medium enterprise call for proposals
The Bidder must be a for-profit with 499 or fewer full-time equivalent (FTE) employees. This calculationFootnote 1 must take into account and include affiliated businesses, such as parent companies and subsidiaries that are either in or outside of Canada.
- research and development activities that take place in Canada
- 50% or more of its annual wages, salaries and fees are currently paid to employees and contractors who spend the majority of their time working in CanadaFootnote 1
- 50% or more of its FTE employees have Canada as their ordinary place of workFootnote 1
- 50% or more of its senior executives (Vice President and above) have Canada as their principal residenceFootnote 1
Under the Innovative Solutions Canada program, an "affiliate" relationship exists in the following situations:
- An affiliate is a corporation that is a subsidiary of another corporation
- If a corporation has two subsidiary corporations, the two subsidiaries are affiliates of each other; or
- If two corporations are controlled by the same individual or business, the two corporations are also affiliates of each other.
A subsidiary is understood to be a business which has more than 50% of its ordinary shares or voting power owned by another business or individual.
Mandatory Criteria (MC)
MC1: Canadian Bidder
The Bidder must meet the definition of a Canadian Bidder. A Canadian Bidder is defined as a Canadian person or entity submitting a proposal on its own behalf and having a place of business in Canada where the person or entity conducts activities on a permanent basis that is clearly identified by name and accessible during normal working hours.
MC2: Canadian Content
80% of the financial proposal costs, the total proposal price to Canada stated in "Section Four – Financial Proposal", must be Canadian goods or Canadian services. For the complete Canadian content definition please refer to the Canadian Content Definition A3050T (2020-07-01) at Part 1, General Information, Article 1.5 of the solicitation documents.
The Bidder must be the owner of the Intellectual Property (IP) for the proposed innovation, or have a licence to the IP rights from a Canadian licensor for the proposed innovation and not be infringing on any IP rights.
MC4: Notice Problem Statement
The Bidder's proposed innovation, as described and in its intended application, must provide a relevant solution to the problem described in the Problem Statement of the Demand Notice.
MC5: Pre-Commercial Status
The proposed innovation must not be openly available in the marketplace, and must not have been previously sold on a commercial basis as of the date of this bid submission. Refer to the definitions of "Pre-Commercial Innovation and Commercial Sales" at Appendix 2 of the solicitation documents.
MC6: Previously Pre-qualified Innovation
The proposed innovation or any other versions of the proposed innovation must not have been previously awarded a contract or grant in the Build in Canada Innovation Program (BCIP) or its predecessor, the Canadian Innovation Commercialization Program (CICP), nor under any Innovative Solutions Canada (ISC) Streams.
The proposed innovation or any other versions of the proposed innovation must not currently be active in a pool of pre-qualified innovations in any of the above. A proposed innovation that is currently active in a pool will be accepted only once the bid validity period for that proposal has expired or the Bidder has withdrawn their innovation from the relevant pool, prior to solicitation closing date.
A Bidder can participate more than once, as long as the proposed innovations are sufficiently different. If the proposed innovation resembles an innovation that is currently active in a pool and has not been withdrawn prior to solicitation closing, the following assessment will be used to determine sufficient difference to proceed.
|Not Sufficiently Different
MC7: Maximum Funding
The Bidder's Financial Proposal must not exceed $550,000 CAD not including applicable taxes, shipping costs, and travel and living expenses, where applicable. Refer to Section H – Financial Proposal.
MC8: Program Eligibility
The Bidder's proposal must be aligned with the mandate of the ISC Testing Stream where Canada procures, through a Contract, the Bidder's Innovation with the purpose of testing it in an operational environment.
MC9: Small Business
The Bidder must be a for-profit person or entity, with 499 or fewer full-time equivalent (FTE) employees. This calculation must take into account and include affiliated businesses, such as parent companies and subsidiaries that are either in or outside of Canada.
MC10: Bidder Presence in Canada
The Bidder must meet the following minimum requirements: 50% or more of the Bidder's FTE employees have Canada as their ordinary place of work; 50% or more of the Bidder's annual wages, salaries and fees must be paid to employees and contractors who spend the majority of their time working in Canada; and 50% or more of the Bidder's senior executives (Vice President and above) have Canada as their principal residence. These calculations must take into account and include affiliated businesses, such as parent companies and subsidiaries that are either in or outside of Canada.
Stage 1 Technical Evaluation – Screening Criteria (SC)
The proposed innovation must meet one or more of the ISC definitions of innovation below:
- An inventionFootnote 2, new technology or new process that is not currently available in the marketplace.
- Significant modifications to the application of existing technologies/components/processes that are applied in a setting or condition for which current applications are not possible or feasible.
- An improvement in functionality, cost or performance over an existing technology/process that is considered state-of-the-art or the current industry best practice.
|The proposed innovation meet one or more of the ISC definitions of innovation.
SC2: Operational Readiness Validation
The Bidder must demonstrate that at the time of proposal submission, the proposed innovation is ready for testing in an operational environment, i.e. at minimum TRL 7 per the ISC Technology Readiness Level Scale.
SC3: Safety Considerations
The Bidder must demonstrate that they have obtained or possess, at the time of proposal submission, the certifications, licences, and approvals required to safely deploy the proposed innovation, and that it poses no risks to individuals or Government of Canada organizations involved in an operational demonstration.
This is to ensure that a Government of Canada organization and personnel are not exposed to safety or privacy risks during the conduct of the operational demonstration.
|At the time of proposal submission:
|At the time of proposal submission:
SC4: Scope – Essential Outcomes
The Bidder must demonstrate that the proposed innovation provides a solution to the Problem Statement, and meets all of the Essential Outcomes identified in the Demand Notice.
Stage 2 Technical Evaluation – Point-Rated Screening Criteria (PS)
PS1: Advance on State of the Art
The Bidder must demonstrate that the proposed innovation improves upon current approaches and state of the art, or current practices relevant to its purpose or application, in a manner that yields competitive advantages.
PS2: Intellectual Property (IP) Strategy
The Bidder must demonstrate a suitable Intellectual Property (IP) strategy, relevant to protect IP generated by the proposed innovation and to protect the Bidder. This criteria also assesses the degree to which the strategy is appropriate to support successful commercialization.
|The Intellectual Property (IP) strategy is insufficiently rationalized or substantiated, and is poorly suited for background IP or generated IP as they pertain to the proposed innovation.
PS3: Management Team
The Bidder must demonstrate that they have filled the key roles in the management team with individuals possessing relevant background or skill setFootnote 3, who can support the successful commercialization of the proposed innovation.
- Role A: Company leadership (e.g. CEO, or equivalent)
- Role B: Technology development (e.g. CTO, or equivalent)
- Role C: Commercialization strategy (e.g. Business Manager, or equivalent)
- Role D: Financial management (e.g. CFO, or equivalent)
|All roles are identified and possess a background or skill set (education and/or experience) that is relevant to the company's activities or their respective fields, however gaps remain that are unmitigated and have the potential to impede commercial launch and commercial success.
|All roles are identified and possess, or are supported by, a background or skill set (education and/or experience) that is relevant to the company's activities or their respective fields, and will likely enable them to reach commercial launch.
|All roles are identified and possess, or are supported by, a strong background or skill set (education and/or experience) that would serve well in commercializing the proposed innovation, is clearly relevant to their respective industry, and increases the likelihood of commercial success.
PS4: Financial Capacity
The Bidder must demonstrate that they have sufficient financial resources and a credible financial strategy in order to execute their commercial launch plan, without a potential ISC Testing Stream contract.
In determining the credibility of a financial strategy, evaluators consider: funding sources, the amount of secured and unsecured funds, the degree of risk, and whether these risks are reasonable or sufficiently mitigated based on the context of the sector. Credibility, potential risks, and applicability to support launch costs should also be considered.
Financial resources must demonstrate ability to commercialize the proposed innovation.
|The Bidder has demonstrated they have sufficient secured funds and have a credible financial strategy to successfully commercialize the proposed innovation.
Stage 3 Technical Evaluation – Point Rated Criteria (PR)
PR1: Innovation Benefits
This criterion is intended to assess the degree to which the proposed innovation could contribute to the positive economic development of the innovation ecosystem in Canada.
|Economic benefits are not identified or are insufficient.
|Economic benefits to the innovation ecosystem in Canada are limited.
|Economic benefits to the innovation ecosystem in Canada are significant.
PR2: Operational Demonstration Risk Mitigation Strategies
PR3: Equity, Diversity, and Inclusion (EDI) Benefits
This criterion is intended to assess the degree to which the Bidder has sufficient measures to effectively achieve and maintain gender balance and diversity within; their business, supply chain, or business ecosystem.
Percentages noted are the number of the following elements the Bidder addressed in their answer:
- Anti-discrimination policies;
- Recruitment strategy and hiring process;
- Training available for to educate the Bidder's workforce on diversity and inclusion;
- How diversity and inclusion are factored into Bidder's supplier selection methods.
|Policies regarding gender balance and diversity are not identified, are insufficient, or do not appear genuine.
|Information provided clearly demonstrates that the Bidder is implementing some measures (up to two (2) elements) to achieve and maintain gender balance and increase diversity.
|Information provided clearly demonstrates that the Bidder is implementing most measures (two (2) or more elements) to achieve and maintain gender balance and increase diversity.
|Information provided clearly demonstrates that the Bidder is implementing all measures (all four (4) elements) to achieve and maintain gender balance and increase diversity.
PR4: Commercialization Strategy and Market Risks
This criterion is intended for the Bidder to demonstrate that they have a credible strategy to commercialize the proposed innovation, identifying market risks and providing suitable mitigation strategies for these risks.
PR5: Adoption Potential – Features & Benefits, Target Market
This criterion is intended to assess to what degree the proposed innovation's features and benefits are attractive to the relevant target market.
PR6: Adoption Potential – Cost to End User
This criterion is intended to assess to what degree the cost of the proposed innovation and the efforts required to adopt it are attractive and relevant for the target market.
The acquisition costs of the proposed innovation include the intended market price, the organizational impact, time and resources required for training and installation, and other direct costs for target market end-user (the customer) to acquire the proposed innovation.
|In relation to the acquisition cost and key features and benefits, an unacceptable amount of time and resources are required for the end user to adopt the proposed innovation.
|In relation to the acquisition cost and key features and benefits, a significant amount of time and resources are required for the end user to adopt the proposed innovation.
|In relation to the acquisition cost and key features and benefits, a reasonable amount of time and resources are required for the end user to adopt the proposed innovation.
|In relation to the acquisition cost and key features and benefits, virtually no time and resources are required for the end user to adopt the proposed innovation.
PR7: Scope – Additional Outcomes
If no Additional Outcomes are identified in the Demand Notice, Bidders will be awarded 16 points.
|Insufficient or no information was provided to clearly demonstrate that the proposed innovation addresses any of the Additional Outcomes identified in the Demand Notice.
|Information provided clearly demonstrates that the proposed innovation addresses some (< 50%) of the Additional Outcomes.
|Information provided clearly demonstrates that the proposed innovation addresses most (50% or more and < 100%) of the Additional Outcomes.
|Information provided clearly demonstrates that the proposed innovation addresses all (100%) of the Additional Outcomes.
Maximum available points from Stage 2 & Stage 3 : 192 points
Minimum Total ScoreFootnote 4 from Stage 2 & Stage 3 to pre-qualify: 115 points
Pathway to commercialization
Enabling the Government of Canada to buy what it tries – a Pathway to Commercialization for eligible Canadian SMEs
Innovative Solutions Canada (ISC) is pleased to be piloting a Pathway to Commercialization under its Testing Stream. Established under the Call for Proposals dedicated to Canadian small and medium enterprises (SMEs), this opportunity will enable eligible SMEs to receive commercial contracts based on the successful testing of their pre-commercial prototype and fulfilment of related readiness requirements. It is important to note that this flexibility will only be available to eligible Canadian SMEs, which represent over 97% of all businesses in Canada, a percentage that mirrors past participation in the program.
- Government of Canada organizations will be able to purchase successfully tested prototypes through the Pathway to Commercialization, without the requirement for additional competition for up to a period of three years.
- The requirements for commercial contracts will reflect the operational needs of client departments, the nature of the innovation, as well as input from Public Services and Procurement Canada, the program's Contracting Authority.
- Contracts under this initiative will each have a limit of up to $8M.
- This feature is expected to increase the Government of Canada's support for the growth and scale up of innovative SMEs.
- The Pathway to Commercialization will complement the Testing Stream's existing Additional Testing component, which enables GC organizations to buy and further test additional quantities of already qualified prototypes. Unlike Pathway to Commercialization contracts, Additional Testing contracts are still considered R&D contracts, similar to the initial Testing Stream contract.
- Additional testing opportunities are open to all program participants, SMEs and non-SMEs.
- A Pathway to Commercialization already exists under the program's Challenge Stream as Phase 3, and reflects ISC's commitment to bringing the program into closer alignment with the highly successful US Small Business Innovation Program after which it was modelled.
How will the Pathway to Commercialization feature work?
- Once their initial ISC testing contract is completed, eligible ISC innovators will have up to 12 months to be assessed against criteria (see point 3 below), which would determine whether they are eligible to be placed on the Pathway to Commercialization source list of approved innovations.
- Innovations on the source list will be available for purchase for up to three years.
- A number of criteria will be used as part of the assessment process, including:
- Financial capacity
- Technology readiness
- IP strategy
- Company size
- Innovation test performance
Frequently asked questions
Can Canada confirm if there is a maximum size business that can apply to Call for Proposals (CFP) EN578-22ISC3?
This Call for Proposal is targeting small businesses of 499 or fewer full-time equivalent (FTE) employees.
What is the purpose of two Testing Stream Calls for Proposals EN578-22ISC3 and EN578-22SC4?
Canada's intent is to allow, through two distinct Calls for Proposals, all eligible businesses to propose their innovations. The first Call for Proposals will target eligible Canadian small businesses and the second will be open to eligible Canadian businesses and entities who are large companies, non-profit, universities, etc.
Can Bidders apply to both CFPs?
No. Bidders must determine under which Call for Proposals they are eligible by referring to Article 1.3 Who Can Submit a Proposal. Bidders are only eligible to apply under one Call for Proposals.
What are the steps for submitting a proposal under the Testing Stream?
As per the solicitation document Article 3.1. Proposal Submission sub article 3.1.2, Bidders must submit their proposal using the Testing Stream Electronic Proposal Submission Form. The form can be found by clicking the "Submit your Proposal" button on the ISC website. Proposals that are submitted in an alternate format will not be accepted unless prior approval has been obtained from the Contracting Authority at: TPSGC.PASICVoletessai-APISCTestingStream.PWGSC@tpsgc-pwgsc.gc.ca
Is there an option to submit to this Call for Proposals using a PDF form or to provide attachments?
There is no option to upload additional information. The innovation description should be presented in the form as requested. In exceptional circumstances only, the following sub articles will apply:
"3.1.5 Bidders who are not able to submit their proposal using the web-based system must contact the Contracting Authority at TPSGC.PASICCOVID19-PISCCOVID19.PWGSC@tpsgc-pwgsc.gc.ca to arrange delivery of their proposal. This includes the submission of proposals with a security level exceeding Protected B."
"3.1.6 All proposals submitted will be bound by the same terms, conditions and limitations. For all proposals submitted, any text submitted above the character limit specified in the Testing Stream Electronic Proposal Submission Form will not be evaluated."
Is there potential relief available on the 80% Canadian content requirement for prototype subcomponent materiel?
At this time the Testing Stream is not considering reducing the Canadian Content Requirement therefore Bidders must ensure innovations demonstrate 80% Canadian Content in accordance with article 1.5 Canadian Content A3050T (2020-07-01) Canadian Content Definition of the solicitation document in order to be considered for this requirement.
The SACC 2040 (2021-12-02), General Conditions – Research & Development section 2040 26 (2008-05-12) Liability clause included in the Resulting Contract states that "The Parties agree that no limitation of liability or indemnity provision applies to the Contract unless it is specifically incorporated in full text in the Articles of the Agreement". Is this clause mandatory, i.e. if the innovation gets selected through the process and a department is interested in procuring it, would we have to sign an unlimited liability clause?
The Draft Resulting Contract Clauses included in the solicitation document at Appendix 3, remains silent on liability in accordance with 2040 (2020-05-28), General Conditions – Research & Development section 2040 26 (2008-05-12) Liability below. All testing stream contracts generally do not include clauses that limit liability as they involve R&D tests for which risks are mitigated through the design and implementation of the test plan. Therefore contracts will rely on the default clause below.
"The Contractor is liable for any damage caused by the Contractor, its employees, subcontractors, or agents to Canada or any third party. Canada is liable for any damage caused by Canada, its employees or agents to the Contractor or any third party. The Parties agree that no limitation of liability or indemnity provision applies to the Contract unless it is specifically incorporated in full text in the Articles of Agreement. Damage includes any injury to persons (including injury resulting in death) or loss of or damage to property (including real property) caused as a result of or during the performance of the Contract."
Regarding the Mandatory Criteria MC5 Pre-Commercial Status of the Calls for Proposals, would Canada consider removing / relaxing the requirement that: "The proposed innovation must not be openly available in the marketplace, and must not have been previously sold on a commercial basis as of the date of this bid submission."
At this point, Canada is not considering removing this requirement for this Call for Proposals.
Does Canada require a company that does safety testing on equipment to provide certification prior to the equipment being complete?
Bidders must demonstrate, at time of proposal submission that their proposed innovation is safe to test in an operational environment.
Can Bidders submit more than one proposal?
Yes. Bidders can submit more than one proposal, so long as it is for distinct innovations.
Can a university submit a proposal for this call?
In order to submit a proposal, Bidders must comply with all the requirements of the Calls for Proposals, including Article 1.3 Who Can Submit a Proposal. In general universities are eligible for Call for Proposals EN578-22ISC4, however the proposal is evaluated on areas which include management team and commercialization plan. Joint-ventures are eligible under this CFP, which could include a University working with a for-profit enterprise.
Can Canada advise as to when announcements will be made regarding the successful applicants? Will a Bidder with a pre-qualified proposal that has been selected by a Government of Canada organization, and that has a verified capacity to undertake the Work as per an agreed-upon SOW, be precluded from completing the contract award process if the Bidder has no financial history by virtue of the fact that it is a new start-up company?
All prequalified Bidders who are selected by a Government of Canada organization will be required to undergo the Contract Award Process outlined in the Call for Proposals at sub articles 5.2 and 5.3. Canada reserves the right to verify the financial capability of a Bidder prior to proceeding with Contract Award, as per sub article 5.3.3 Financial Capability.
What is the Pathway to Commercialization (Direct Buy) and intent?
Pathway to Commercialization (Direct Buy) is an initiative that Innovative Solutions Canada is piloting to better support both small businesses and government organizations. Pathway to Commercialization will allow government organizations to commercially buy the innovation, within a pre-established framework, in larger quantities to meet operational requirements without having to compete for it through normal competitive vehicles. This pilot initiative will be open to contractors who have completed an initial contract resulting from this call for proposals EN578-22ISC3 and met the entry requirements of the Direct Buy pilot.
Canada's intent is to determine the feasibility of implementing this initiative on a long-term basis. This will be achieved by monitoring the process, gathering data and analyzing the benefits and disadvantages for Canada. Canada will determine if it is beneficial to proceed with a direct buy or compete the requirement separately through other methods of supply to meet operational requirements.
Can Bidders apply directly to the Pathway to Commercialization (Direct Buy) pilot?
Only Small Canadian businesses who have received and completed an initial ISC contract as a result of CFP EN578-22ISC3, and whose innovation has reached the end of the TRL scale and are ready for market may participate in the Pathway to Commercialization pilot.
Will the same terms and conditions as standard R&D apply to the Direct Buy pilot?
Direct Buy Contracts will use different terms and conditions that are commodity-specific, outside of the R&D umbrella. Various terms and conditions that may be used are listed on Buy and Sell.
Will Direct Buy contracts need to be competed separately?
Direct Buy Contracts will not be competed per se though eligible small businesses will be required to re-certify eligibility to enter the Pathway to Commercialization (Direct Buy), meet additional criteria outlined in Appendix 5 of the Call for Proposals EN578-22ISC3 and agree to the new terms and conditions of any resulting Direct Buy Contract.